Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $177,079 - $206,789
-1,144 Reduced 44.65%
1,418 $243,000
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $17,420 - $19,848
109 Added 4.44%
2,562 $466,000
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $16,649 - $18,751
-121 Reduced 4.7%
2,453 $380,000
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $16,164 - $18,712
121 Added 4.93%
2,574 $383,000
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $265 - $329
-2 Reduced 0.08%
2,453 $330,000
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $23,097 - $27,700
167 Added 7.3%
2,455 $396,000
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $27,110 - $31,093
-202 Reduced 8.11%
2,288 $307,000
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $963 - $1,224
-7 Reduced 0.28%
2,490 $381,000
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $3,167 - $3,930
-24 Reduced 0.95%
2,497 $405,000
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $240,965 - $304,890
-2,243 Reduced 47.08%
2,521 $341,000
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $166,409 - $188,899
-1,564 Reduced 24.72%
4,764 $514,000
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $19,148 - $21,332
-182 Reduced 2.8%
6,328 $713,000
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $117,645 - $129,513
1,150 Added 21.46%
6,510 $704,000
Q4 2020

Feb 18, 2021

BUY
$80.49 - $108.67 $1,207 - $1,630
15 Added 0.28%
5,360 $574,000
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $2,405 - $2,823
28 Added 0.53%
5,345 $468,000
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $30,301 - $40,548
413 Added 8.42%
5,317 $522,000
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $8,965 - $13,592
139 Added 2.92%
4,904 $374,000
Q4 2019

Feb 24, 2020

SELL
$72.13 - $90.25 $9,521 - $11,913
-132 Reduced 2.7%
4,765 $422,000
Q3 2019

Nov 15, 2019

BUY
$62.98 - $75.72 $2,834 - $3,407
45 Added 0.93%
4,897 $371,000
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $112,806 - $144,193
1,717 Added 54.77%
4,852 $353,000
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $1,868 - $2,304
24 Added 0.77%
3,135 $289,000
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $1,956 - $2,174
22 Added 0.71%
3,111 $294,000
Q2 2018

Aug 15, 2018

SELL
$89.78 - $106.23 $27,113 - $32,081
-302 Reduced 8.91%
3,089 $286,000
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $10,949 - $14,661
119 Added 3.64%
3,391 $321,000
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $10,209 - $11,195
114 Added 3.61%
3,272 $316,000
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $220,586 - $281,756
3,158
3,158 $281,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Circle Wealth Management, LLC Portfolio

Follow Circle Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Circle Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Circle Wealth Management, LLC with notifications on news.